| Surgical or endovascular treatment for chronic mesenteric ischemia: a multicenter study. | |
| | |
MedLine Citation:
|
PMID: 20831994 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: To evaluate treatment options for patients with chronic mesenteric ischemia in the United Kingdom. METHODS: Early and late outcomes of patients with chronic mesenteric ischemia who underwent bypass or percutaneous angioplasty (PTA) in 12 centers were compared on an intention-to-treat basis. RESULTS: A total of 76 patients underwent 101 procedures (PTA 49; bypass 52). Of these, 36 had a PTA first, and 40 had a bypass first. Among those who underwent a primary PTA, nine required a subsequent bypass. Three patients who underwent a primary bypass also required a graft PTA, and three patients required further surgery. Patients who underwent a primary PTA were found to be significantly older and tended to have greater comorbidities. As compared with PTA, primary bypasses were more frequently undertaken in an urgent manner or as an emergency (43% vs. 8%). Perioperative morbidity for bypass was significantly greater than that for PTA (32% vs. 6%). Overall, 30-day mortality for bypass tended to be greater than that for PTA (13% vs. 4%; n.s.), but was similar for patients treated electively in the two groups (4% vs. 3%). Cumulative 1- and 5-year survival (bypass: 85%, 63%; PTA: 67%, 31%) and primary patency (bypass: 81%, 69%; PTA: 54%, 32%) rates were found to be significantly better after primary bypass. CONCLUSIONS: Treatment preferences were center-dependent. Symptomatic recurrence was found to be less frequent and patency rates were better after a primary bypass. PTA may be a viable alternative in patients with significant comorbidities. |
| | |
Authors:
|
Nihit Rawat; Christopher P Gibbons; |
Related Documents
:
|
20839344 - Orbital atherectomy for symptomatic lower extremity disease. 23017514 - Favorable patient reported outcomes following penile plication for wide array of peyron... 16414384 - Endovascular management of iliac artery occlusions: extending treatment to transatlanti... 18670374 - Invasive treatment for renovascular disease. a twenty year experience from a population... 20546174 - Effects of chemical activation treatment on development of swamp buffalo (bubalus bubal... 22219604 - Self-expanding metallic esophageal stents: a long way to go before a particular stent c... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Multicenter Study |
Journal Detail:
|
Title: Annals of vascular surgery Volume: 24 ISSN: 1615-5947 ISO Abbreviation: Ann Vasc Surg Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-13 Completed Date: 2011-01-11 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8703941 Medline TA: Ann Vasc Surg Country: United States |
Other Details:
|
Languages: eng Pagination: 935-45 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Morriston Hospital, Morriston, Swansea, United Kingdom. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aged, 80 and over Angioplasty, Balloon* / adverse effects, instrumentation, mortality Chronic Disease Comorbidity Endovascular Procedures* / adverse effects, instrumentation, mortality Female Great Britain Humans Ischemia / mortality, physiopathology, surgery, therapy* Kaplan-Meier Estimate Male Mesenteric Vascular Occlusion / mortality, physiopathology, surgery, therapy* Middle Aged Patient Selection Proportional Hazards Models Recurrence Reoperation Retrospective Studies Risk Assessment Risk Factors Stents Treatment Outcome Vascular Patency Vascular Surgical Procedures* / adverse effects, mortality |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Endovascular abdominal aortic aneurysm repair using an anatomical fixation technique and concomitant...
Next Document: Long-term outcome of inferior vena cava filter placement in patients undergoing gastric bypass.